Amelie Guyot

HERMESA is a UK based angel syndicate investing in extraordinary female (co)founded start-ups. We are a community of operators who know what it takes to build successful start-ups and we invest smart money – capital and expertise – to help change the funding landscape for women founders.

Juniver is revolutionizing eating disorder care with the first AI-powered digital therapeutic solution. Our award-winning patient service combines cutting-edge technology with clinical expertise to deliver personalized, in-the-moment support for the 1 in 10 people affected by eating disorders. We also serve clinicians through two product offerings: Juniver for Clinicians equips eating disorder clinics and providers with technology to extend care beyond the clinic walls, and JuniCare is a tech-enabled wraparound service that includes care coordination, behavioral health support, and adherence tools. Through this platform, Juniver is building real-world datasets that can transform our understanding of eating disorders and how to make treatment more effective. We are backed by leading investors including Morgan Stanley, Blue Cross Blue Shield, Ascension Ventures, and Stardust Equity. 🏆 4.7/5 Global App Store Rating 🤝 Trusted by Patients and Providers 🔬 Building the Worlds Largest Eating Disorder Dataset 🌟 Award-Winning Platform

We are Investors and Scientists We source world-class scientific discoveries, provide unique scientific due diligence and help our members to identify exceptional investment opportunities. Our collective knowledge helps our members invest in the most exciting companies of tomorrow, founded by leading scientists at the forefront of their fields. We aim to discover companies that will grow rapidly and tackle the most important global challenges.

The reference early stage investor for UK climate innovation. Green Angel Ventures specialises in the fight against climate change. Our funds and syndicate provide the knowledge and experience needed to add substantial value to emerging climate start-ups. We invest in the businesses with the solutions to beat climate change. Our Syndicate has over 350 members and has invested in 45 start-up and early-stage companies across 10 different economic sectors. Our Climate Change Fund is an EIS fund investing alongside our specialist Syndicate members.

Empirical Ventures leads pre-seed and seed rounds for deep science startups that are creating century-defining technologies 🚀

Life Science Angels (LSA) is the premier angel investing organization in the US, focused on investing exclusively in the life sciences. Since 2005, LSA has invested in 100+ companies in medical technology and biotechnology investment opportunities.

HERMESA is a UK based angel syndicate investing in extraordinary female (co)founded start-ups. We are a community of operators who know what it takes to build successful start-ups and we invest smart money – capital and expertise – to help change the funding landscape for women founders.

Juniver is revolutionizing eating disorder care with the first AI-powered digital therapeutic solution. Our award-winning patient service combines cutting-edge technology with clinical expertise to deliver personalized, in-the-moment support for the 1 in 10 people affected by eating disorders. We also serve clinicians through two product offerings: Juniver for Clinicians equips eating disorder clinics and providers with technology to extend care beyond the clinic walls, and JuniCare is a tech-enabled wraparound service that includes care coordination, behavioral health support, and adherence tools. Through this platform, Juniver is building real-world datasets that can transform our understanding of eating disorders and how to make treatment more effective. We are backed by leading investors including Morgan Stanley, Blue Cross Blue Shield, Ascension Ventures, and Stardust Equity. 🏆 4.7/5 Global App Store Rating 🤝 Trusted by Patients and Providers 🔬 Building the Worlds Largest Eating Disorder Dataset 🌟 Award-Winning Platform

We are Investors and Scientists We source world-class scientific discoveries, provide unique scientific due diligence and help our members to identify exceptional investment opportunities. Our collective knowledge helps our members invest in the most exciting companies of tomorrow, founded by leading scientists at the forefront of their fields. We aim to discover companies that will grow rapidly and tackle the most important global challenges.

The reference early stage investor for UK climate innovation. Green Angel Ventures specialises in the fight against climate change. Our funds and syndicate provide the knowledge and experience needed to add substantial value to emerging climate start-ups. We invest in the businesses with the solutions to beat climate change. Our Syndicate has over 350 members and has invested in 45 start-up and early-stage companies across 10 different economic sectors. Our Climate Change Fund is an EIS fund investing alongside our specialist Syndicate members.